Unraveling the Guardian: p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms without original human data or systematic review methodology.
PubMed 39684639 · doi:10.3390/ijms252312928
What was done
This narrative review summarizes the molecular mechanisms of p53 activation during the DNA damage response, its downstream regulation of cell cycle checkpoints, DNA repair, and apoptosis, as well as therapeutic approaches targeting p53 in oncology.
What was found
The abstract reports no quantitative data or numerical findings. It qualitatively describes how DNA damage activates p53 via post-translational modifications to arrest the cell cycle at G1/S and G2/M checkpoints, stimulate DNA repair pathways such as base and nucleotide excision repair, or induce apoptosis when damage is irreparable. It also outlines therapeutic strategies including restoring wild-type p53 function, inhibiting negative regulators, and exploiting synthetic lethality in p53-deficient tumors.
Why it matters
The paper summarizes the central role of p53 in genomic integrity maintenance and outlines major pharmacological approaches for targeting p53 pathways in cancer therapy.
Limits
The abstract describes a narrative review with no original experimental data, quantitative synthesis, or systematic search methodology. Clinical efficacy, safety, and trial metrics for the therapeutic strategies are not reported.
Cited by
- supports Tumor suppressor genes protect against cancer by triggering cell death when cellular damage occurs.